TY - JOUR
T1 - Adipose Stem Cells Used to Reconstruct 13 Cases With Cranio-Maxillofacial Hard-Tissue Defects
AU - Sándor, George
AU - Numminen, Jura
AU - Wolff, Jan
AU - Thesleff, Tuomo
AU - Miettinen, Aimo
AU - Tuovinen, Veikko J.
AU - Mannerstrom, Bettina
AU - Patrikoski, Mimmi
AU - Seppänen, Riitta
AU - Miettinen, Susanna
AU - Rautiainen, Markus
AU - Ohman, Juha
N1 - INT=elt,"Seppänen, Riitta"
PY - 2014
Y1 - 2014
N2 - Although isolated reports of hard-tissue reconstruction in the cranio-maxillofacial skeleton exist, multipatient case series are lacking. This study aimed to review the experience with 13 consecutive cases of cranio-maxillofacial hard-tissue defects at four anatomically different sites, namely frontal sinus (3 cases), cranial bone (5 cases), mandible (3 cases), and nasal septum (2 cases). Autologous adipose tissue was harvested from the anterior abdominal wall, and adipose-derived stem cells were cultured, expanded, and then seeded onto resorbable scaffold materials for subsequent reimplantation into hard-tissue defects. The defects were reconstructed with either bioactive glass or p-tricalcium phosphate scaffolds seeded with adipose-derived stem cells (ASCs), and in some cases with the addition of recombinant human bone morphogenetic protein-2. Production and use of ASCs were done according to good manufacturing practice guidelines. Follow-up time ranged from 12 to 52 months. Successful integration of the construct to the surrounding skeleton was noted in 10 of the 13 cases. Two cranial defect cases in which nonrigid resorbable containment meshes were used sustained bone resorption to the point that they required the procedure to be redone. One septal perforation case failed outright at 1 year because of the postsurgical resumption of the patient's uncontrolled nasal picking habit.
AB - Although isolated reports of hard-tissue reconstruction in the cranio-maxillofacial skeleton exist, multipatient case series are lacking. This study aimed to review the experience with 13 consecutive cases of cranio-maxillofacial hard-tissue defects at four anatomically different sites, namely frontal sinus (3 cases), cranial bone (5 cases), mandible (3 cases), and nasal septum (2 cases). Autologous adipose tissue was harvested from the anterior abdominal wall, and adipose-derived stem cells were cultured, expanded, and then seeded onto resorbable scaffold materials for subsequent reimplantation into hard-tissue defects. The defects were reconstructed with either bioactive glass or p-tricalcium phosphate scaffolds seeded with adipose-derived stem cells (ASCs), and in some cases with the addition of recombinant human bone morphogenetic protein-2. Production and use of ASCs were done according to good manufacturing practice guidelines. Follow-up time ranged from 12 to 52 months. Successful integration of the construct to the surrounding skeleton was noted in 10 of the 13 cases. Two cranial defect cases in which nonrigid resorbable containment meshes were used sustained bone resorption to the point that they required the procedure to be redone. One septal perforation case failed outright at 1 year because of the postsurgical resumption of the patient's uncontrolled nasal picking habit.
KW - Adipose stem cells
KW - Bioactive glass
KW - Bone morphogenetic protein
KW - DONOR-SITE MORBIDITY
KW - GROWTH-FACTOR
KW - HUMAN OSTEOGENIC PROTEIN-1
KW - MANDIBULAR RECONSTRUCTION
KW - VASCULARIZED BONE-GRAFT
KW - beta-Tricalcium phosphate
KW - Adipose stem cells
KW - Bioactive glass
KW - Bone morphogenetic protein
KW - DONOR-SITE MORBIDITY
KW - GROWTH-FACTOR
KW - HUMAN OSTEOGENIC PROTEIN-1
KW - MANDIBULAR RECONSTRUCTION
KW - VASCULARIZED BONE-GRAFT
KW - beta-Tricalcium phosphate
U2 - 10.5966/sctm.2013-0173
DO - 10.5966/sctm.2013-0173
M3 - Article
SN - 2157-6564
VL - 3
SP - 530
EP - 540
JO - Stem Cells Translational Medicine
JF - Stem Cells Translational Medicine
IS - 4
ER -